The impact of anatomical changes during photon or proton based radiation treatment on tumor dose in glioblastoma dose escalation trials
AuthorsHessen, E. D.
van der Heide, U. A.
Lutkenhaus, L. J.
Troost, Esther G C
Borst, G. R.
AffiliationDepartment of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
MetadataShow full item record
AbstractPurpose/objective: Most dose-escalation trials in glioblastoma patients integrate the escalated dose throughout the standard course by targeting a specific subvolume. We hypothesize that anatomical changes during irradiation may affect the dose coverage of this subvolume for both proton- and photon-based radiotherapy. Material and methods: For 24 glioblastoma patients a photon- and proton-based dose escalation treatment plan (of 75 Gy/30 fr) was simulated on the dedicated radiotherapy planning MRI obtained before treatment. The escalated dose was planned to cover the resection cavity and/or contrast enhancing lesion on the T1w post-gadolinium MRI sequence. To analyze the effect of anatomical changes during treatment, we evaluated on an additional MRI that was obtained during treatment the changes of the dose distribution on this specific high dose region. Results: The median time between the planning MRI and additional MRI was 26 days (range 16-37 days). The median time between the planning MRI and start of radiotherapy was relatively short (7 days, range 3-11 days). In 3 patients (12.5%) changes were observed which resulted in a substantial deterioration of both the photon and proton treatment plans. All these patients underwent a subtotal resection, and a decrease in dose coverage of more than 5% and 10% was observed for the photon- and proton-based treatment plans, respectively. Conclusion: Our study showed that only for a limited number of patients anatomical changes during photon or proton based radiotherapy resulted in a potentially clinically relevant underdosage in the subvolume. Therefore, volume changes during treatment are unlikely to be responsible for the negative outcome of dose-escalation studies.
CitationHessen ED, Makocki S, van der Heide UA, Jasperse B, Lutkenhaus LJ, Lamers E, et al. The impact of anatomical changes during photon or proton based radiation treatment on tumor dose in glioblastoma dose escalation trials. Vol. 164, Radiotherapy and Oncology. Elsevier BV; 2021. p. 202�8.
JournalRadiotherapy and Oncology
- A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
- Authors: Weber DC, Trofimov AV, Delaney TF, Bortfeld T
- Issue date: 2004 Apr 1
- Proton vs. photon radiotherapy for MR-guided dose escalation of intraprostatic lesions.
- Authors: Moteabbed M, Harisinghani M, Paganetti H, Trofimov A, Lu HM, Efstathiou JA
- Issue date: 2021 Oct
- Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
- Authors: Weber DC, Bogner J, Verwey J, Georg D, Dieckmann K, Escudé L, Caro M, Pötter R, Goitein G, Lomax AJ, Miralbell R
- Issue date: 2005 Oct 1
- Proton radiotherapy for liver tumors: dosimetric advantages over photon plans.
- Authors: Wang X, Krishnan S, Zhang X, Dong L, Briere T, Crane CH, Martel M, Gillin M, Mohan R, Beddar S
- Issue date: 2008 Winter
- Short-course PET based simultaneous integrated boost for locally advanced cervical cancer.
- Authors: Arnesen MR, Rekstad BL, Stokke C, Bruheim K, Løndalen AM, Hellebust TP, Malinen E
- Issue date: 2016 Mar 12